Crown Crafts (CRWS) 10-Q 15 Nov 23 2024 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Oct. 01, 2023	Oct. 30, 2023
Document Information [Line Items]
Entity Central Index Key	0000025895
Entity Registrant Name	CROWN CRAFTS INC
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 01, 2023
Document Transition Report	false
Entity File Number	1-7604
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	58-0678148
Entity Address, Address Line One	916 South Burnside Avenue
Entity Address, City or Town	Gonzales
Entity Address, State or Province	LA
Entity Address, Postal Zip Code	70737
City Area Code	225
Local Phone Number	647-9100
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	CRWS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,240,719

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Current assets:
Cash and cash equivalents	$ 1,851	$ 1,742
Accounts receivable (net of allowances of $2,410 at October 1, 2023 and $1,474 at April 2, 2023):
Due from factor	17,091	20,740
Other	3,215	2,068
Inventory, Net	35,257	34,211
Prepaid expenses	1,458	1,614
Total current assets	58,872	60,375
Operating lease right of use assets	15,733	17,305
Property, plant and equipment - at cost:
Vehicles	182	182
Leasehold improvements	480	473
Machinery and equipment	4,802	4,333
Furniture and fixtures	476	408
Property, plant and equipment - gross	5,940	5,396
Less accumulated depreciation	4,109	3,677
Property, plant and equipment - net	1,831	1,719
Finite-lived intangible assets - at cost:
Customer relationships	8,174	8,174
Other finite-lived intangible assets	4,766	4,766
Finite-lived intangible assets - gross	12,940	12,940
Less accumulated amortization	9,766	9,467
Finite-lived intangible assets - net	3,174	3,473
Goodwill	7,875	7,912
Other	197	188
Total Assets	87,682	90,972
Current liabilities:
Accounts payable	7,490	7,548
Accrued wages and benefits	1,062	1,087
Accrued royalties	642	614
Dividends payable	822	815
Operating lease liabilities, current	3,096	2,427
Other accrued liabilities	643	566
Total current liabilities	13,755	13,057
Non-current liabilities:
Long-term debt	9,808	12,674
Deferred income taxes	297	815
Operating lease liabilities, noncurrent	13,306	14,889
Reserve for unrecognized tax liabilities	363	323
Total non-current liabilities	23,774	28,701
Shareholders' equity:
Common stock - $0.01 par value per share; Authorized 40,000,000 shares at October 1, 2023 and April 2, 2023; Issued 13,138,226 shares at October 1, 2023 and 13,051,814 shares at April 2, 2023	131	131
Additional paid-in capital	57,509	57,126
Treasury stock - at cost - 2,897,507 shares at October 1, 2023 and April 2, 2023	(15,821)	(15,821)
Retained Earnings	8,334	7,778
Total shareholders' equity	50,153	49,214
Total Liabilities and Shareholders' Equity	$ 87,682	$ 90,972

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Allowance for doubtful accounts receivable	$ 2,410	$ 1,474
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	13,138,226	13,051,814
Treasury stock, shares (in shares)	2,897,507	2,897,507

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Net sales	$ 24,129	$ 18,726	$ 41,252	$ 34,436
Cost of products sold	17,533	13,280	29,914	23,837
Gross profit	6,596	5,446	11,338	10,599
Marketing and administrative expenses	4,036	2,736	8,082	6,149
Income from operations	2,560	2,710	3,256	4,450
Other (expense) income:
Interest expense - net of interest income	(164)	4	(352)	1
Gain on insurance proceeds received for damage to equipment	0	0	0	34
Gain on sale of property, plant and equipment	0	0	0	2
Other - net	(24)	(3)	(26)	124
Income before income tax expense	2,372	2,711	2,878	4,611
Income tax expense	550	671	690	1,137
Net income	$ 1,822	$ 2,040	$ 2,188	$ 3,474
Weighted average shares outstanding:
Basic (in shares)	10,199	10,094	10,177	10,085
Effect of dilutive securities (in shares)	2	22	5	22
Diluted (in shares)	10,201	10,116	10,182	10,107
Earnings per share - basic and diluted (in dollars per share)	$ 0.18	$ 0.2	$ 0.21	$ 0.34

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Statements of Changes In Shareholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Treasury Stock, Common [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balances (in shares) at Apr. 03, 2022	12,944,918	(2,864,698)
Balances at Apr. 03, 2022	$ 129	$ (15,614)	$ 55,925	$ 5,361	$ 45,801
Issuance of shares (in shares)	66,896	0
Issuance of shares	$ 1	$ 0	97	0	98
Stock-based compensation	$ 0	$ 0	591	0	591
Acquisition of treasury stock (in shares)	0	(29,544)
Acquisition of treasury stock	$ 0	$ (189)	0	0	(189)
Net income	0	0	0	3,474	3,474
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(1,615)	(1,615)
Balances (in shares) at Oct. 02, 2022	13,011,814	(2,894,242)
Balances at Oct. 02, 2022	$ 130	$ (15,803)	56,613	7,220	48,160
Balances (in shares) at Jul. 03, 2022	12,959,918	(2,890,165)
Balances at Jul. 03, 2022	$ 130	$ (15,776)	56,331	5,989	46,674
Issuance of shares (in shares)	51,896	0
Issuance of shares	$ 0	$ 0	24	0	24
Stock-based compensation	$ 0	$ 0	258	0	258
Acquisition of treasury stock (in shares)	0	(4,077)
Acquisition of treasury stock	$ 0	$ (27)	0	0	(27)
Net income	0	0	0	2,040	2,040
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(809)	(809)
Balances (in shares) at Oct. 02, 2022	13,011,814	(2,894,242)
Balances at Oct. 02, 2022	$ 130	$ (15,803)	56,613	7,220	48,160
Balances (in shares) at Apr. 02, 2023	13,051,814	(2,897,507)
Balances at Apr. 02, 2023	$ 131	$ (15,821)	57,126	7,778	49,214
Issuance of shares (in shares)	86,412	0
Issuance of shares	$ 0	$ 0	0	0	0
Stock-based compensation	0	0	383	0	383
Net income	0	0	0	2,188	2,188
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(1,632)	(1,632)
Balances (in shares) at Oct. 01, 2023	13,138,226	(2,897,507)
Balances at Oct. 01, 2023	$ 131	$ (15,821)	57,509	8,334	50,153
Balances (in shares) at Jul. 02, 2023	13,051,814	(2,897,507)
Balances at Jul. 02, 2023	$ 131	$ (15,821)	57,317	7,332	48,959
Issuance of shares (in shares)	86,412	0
Issuance of shares	$ 0	$ 0	0	0	0
Stock-based compensation	0	0	192	0	192
Net income	0	0	0	1,822	1,822
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(820)	(820)
Balances (in shares) at Oct. 01, 2023	13,138,226	(2,897,507)
Balances at Oct. 01, 2023	$ 131	$ (15,821)	$ 57,509	$ 8,334	$ 50,153

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Changes In Shareholders' Equity (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Dividends declared, per share (in dollars per share)	$ 0.08	$ 0.08	$ 0.16	$ 0.16

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022
Operating activities:
Net income	$ 2,188	$ 3,474
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant and equipment	432	335
Amortization of intangibles	299	241
Amortization of right of use assets	2,074	884
Deferred income taxes	(518)	247
Gain on insurance proceeds received for damage to equipment	0	(34)
Gain on sale of property, plant and equipment	0	(2)
Reserve for unrecognized tax liabilities	40	74
Stock-based compensation	383	591
Changes in assets and liabilities:
Accounts receivable	2,502	5,643
Inventories	(1,434)	(7,082)
Prepaid expenses	156	(112)
Other assets	(9)	0
Lease liabilities	(1,417)	(969)
Accounts payable	(126)	370
Accrued liabilities	80	(1,002)
Net cash provided by operating activities	4,650	2,658
Cash used in investing activities:
Capital expenditures for property, plant and equipment	(539)	(227)
Insurance proceeds received for damage to equpment	0	34
Proceeds from sale of property, plant and equipment	0	2
Aggregate adjustment from the Manhattan and MTE acquisition	488	0
Net cash used in investing activities	(51)	(191)
Financing activities:
Repayments under revolving line of credit	(35,947)	0
Borrowings under revolving line of credit	33,081	0
Purchase of treasury stock from related parties	0	(189)
Issuance of common stock	0	98
Dividends paid	(1,624)	(1,632)
Net cash used in financing activities	(4,490)	(1,723)
Net increase in cash and cash equivalents	109	744
Cash and cash equivalents at beginning of period	1,742	1,598
Cash and cash equivalents at end of period	1,851	2,342
Supplemental cash flow information:
Income taxes paid	875	23
Interest paid	448	5
Noncash activities:
Property, plant and equipment purchased but unpaid	(5)	(25)
Dividends declared but unpaid	$ (822)	$ (809)

Note 1 - Interim Financial Stat

Note 1 - Interim Financial Statements	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 1 Interim Financial Statements Basis of Presentation: not In the opinion of the Company’s management, the unaudited condensed consolidated financial statements contained herein include all adjustments necessary to present fairly the financial position of the Company as of October 1, 2023 three six October 1, 2023 not may March 31, 2024. April 2, 2023, 10 Fiscal Year: March 31. 2024” “2024” 52 March 31, 2024 2023” “2023” 52 April 2, 2023. Recently-Issued Accounting Standards: June 2016, No. 2016 13, Financial Instruments Credit Losses (Topic 326 not No. 2016 13 December 15, 2018. No. 2016 13 no December 15, 2019, November 15, 2019, No. 2019 10, Financial Instruments Credit Losses (Topic 326 815 842 No. 2016 13 first December 15, 2022. No. 2016 13 April 3, 2023. not In October 2023, No. 2023 06, Disclosure Improvements Codification Amendments in Response to the SEC s Disclosure Update and Simplification Initiative August 2018, No. 33 10532, No. 2023 06 14 27 not not no not No. 2023 06 The Company has determined that all other ASUs issued which had become effective as of October 1, 2023, not

Note 2 - Advertising Costs

Note 2 - Advertising Costs	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Advertising Costs [Text Block]	Note 2 Advertising Costs The Company’s advertising costs are primarily associated with cooperative advertising arrangements with certain of the Company’s customers and are recognized using the straight-line method based upon aggregate annual estimated amounts for these customers, with periodic adjustments to the actual amounts of authorized agreements. Advertising expense is included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income and amounted to $172,000 and $123,000 for the three October 1, 2023 October 2, 2022, six October 1, 2023 October 2, 2022,

Note 3 - Segment and Related In

Note 3 - Segment and Related Information	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 3 Segment and Related Information The Company operates primarily in one principal segment, infant, toddler and juvenile products. These products consist of infant and toddler bedding, blankets, accessories, bibs, toys and disposable products. Net sales of bedding, blankets and accessories and net sales of bibs, toys and disposable products for the three six October 1, 2023 October 2, 2022 Three-Month Periods Ended Six-Month Periods Ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Bedding, blankets and accessories $ 9,776 $ 9,503 $ 15,349 $ 17,001 Bibs, toys and disposable products 14,353 9,223 25,903 17,435 Total net sales $ 24,129 $ 18,726 $ 41,252 $ 34,436

Note 4 - Licensing Agreements

Note 4 - Licensing Agreements	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Licensing Agreements [Text Block]	Note 4 Licensing Agreements The Company has entered into licensing agreements that provide for royalty payments based on a percentage of sales with certain minimum guaranteed amounts. These royalty amounts are accrued based upon historical sales rates adjusted for current sales trends by customers. Royalty expense is included in cost of products sold in the accompanying unaudited condensed consolidated statements of income and amounted to $1.5 million and $1.2 million for the three October 1, 2023 October 2, 2022, six October 1, 2023 October 2, 2022,

Note 5 - Income Taxes

Note 5 - Income Taxes	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 5 Income Taxes The Company files income tax returns in the many jurisdictions in which it operates, including the U.S., several U.S. states and the People’s Republic of China. The statute of limitations varies by jurisdiction; tax years open to examination or other adjustment as of October 1, 2023 April 2, 2023, April 3, 2022, March 28, 2021, March 29, 2020 March 31, 2019. In August 2020, April 2, 2017, April 1, 2018 March 31, 2019. May 30, 2023, May 31, 2023. April 2, 2023, April 2, 2023, April 2, 2023 April 2, 2023. Although management believes that the calculations and positions taken on its filed income tax returns are reasonable and justifiable, the outcome of an examination could result in an adjustment to the position that the Company took on such income tax returns. Such adjustment could also lead to adjustments to one not

Note 6 - Inventories

Note 6 - Inventories	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	Note 6 Inventories As of October 1, 2023 April 2, 2023,

Note 7 - Acquisition

Note 7 - Acquisition	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Business Combination Disclosure [Text Block]	Note 7 Acquisition On March 17, 2023 ( September 29, 2023, The Manhattan Acquisition has been accounted for in accordance with FASB ASC Topic 805, Business Combinations third not The acquisition cost paid on the Closing Date amounted to $17.4 million, which included an estimate for cash as of the Closing Date and an estimate for the net working capital acquired. The settlement of the Aggregate Adjustment decreased the acquisition cost to $16.9 million. The following table represents the Company’s preliminary allocation of this acquisition cost (in thousands) to the identifiable assets acquired and the liabilities assumed based on their respective estimated fair values as of the Closing Date. The excess of the acquisition cost over the estimated fair value of the identifiable net assets acquired is reflected as goodwill. Tangible assets: Cash and cash equivalents $ 1,270 Accounts receivable 3,112 Inventories 12,578 Prepaid expenses 350 Other assets 91 Operating lease right of use assets 1,009 Property, plant and equipment 194 Total tangible assets 18,604 Amortizable intangible assets: Tradename 300 Licensing relationships 200 Customer relationships 800 Total amortizable intangible assets 1,300 Goodwill 750 Total acquired assets 20,654 Liabilities assumed: Accounts payable 2,048 Accrued wages and benefits 370 Operating lease liabilities, current 226 Other accrued liabilities 308 Operating lease liabilities, noncurrent 783 Total liabilities assumed 3,735 Net acquisition cost $ 16,919 The Company expects to complete the acquisition cost allocation during the 12 may six October 1, 2023. Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost $ 787,000 Adjustments made during the six-month period ended October 1, 2023: Settlement of the Aggregate Adjustment (488,000 ) Revaluation of inventory as of the Closing Date 387,000 Resolution of pre-acquisition accounts payable 64,000 Net adjustments made during the six-month period ended October 1, 2023 (37,000 ) Amount of goodwill recognized as of October 1, 2023 $ 750,000 The Manhattan Acquisition resulted in net sales of $4.8 million and $8.5 million of developmental toy, feeding and baby care products for the three six October 1, 2023, three six October 1, 2023, The Company has determined, on a pro forma basis, that the combined net sales and the combined net income of the Company and Manhattan, giving effect to the Manhattan Acquisition as if it had been completed on April 4, 2022, three October 2, 2022, six October 2, 2022. not may may

Note 8 - Financing Arrangements

Note 8 - Financing Arrangements	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 8 Financing Arrangements Factoring Agreements: not may may three October 1, 2023 October 2, 2022, six October 1, 2023 October 2, 2022, Credit Facility: October 1, 2023 July 11, 2028, first October 1, 2023, As of October 1, 2023 April 2, 2023, October 1, 2023. Credit Concentration: October 1, 2023 April 2, 2023

Note 9 - Goodwill

Note 9 - Goodwill	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Goodwill Disclosure [Text Block]	Note 9 Goodwill Goodwill represents the excess of the purchase price over the fair value of net identifiable assets acquired in business combinations. For the purpose of presenting and measuring for the impairment of goodwill, the Company has two one October 1, 2023 April 2, 2023 The Company measures for impairment the goodwill within its reporting units annually as of the first not 50% first not not On April 3, 2023, not not

Note 10 - Other Intangible Asse

Note 10 - Other Intangible Assets	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	Note 10 Other Intangible Assets Other intangible assets as of October 1, 2023 April 2, 2023 October 1, 2023 April 2, 2023 three six October 1, 2023 October 2, 2022, Amortization Expense Gross Amount Accumulated Amortization Three-Month Periods Ended Six-Month Periods Ended October 1, April 2, October 1, April 2, October 1, October 2, October 1, October 2, 2023 2023 2023 2023 2023 2022 2023 2022 Tradename and trademarks $ 2,867 $ 2,867 $ 2,103 $ 2,025 $ 43 $ 35 $ 78 $ 70 Non-compete covenants 98 98 98 98 - - - - Patents 1,601 1,601 1,081 1,055 13 13 26 26 Customer relationships 8,174 8,174 6,474 6,289 92 73 185 145 Licensing relationships 200 200 10 - 5 - 10 - Total other intangible assets $ 12,940 $ 12,940 $ 9,766 $ 9,467 $ 153 $ 121 $ 299 $ 241

Note 11 - Leases

Note 11 - Leases	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	Note 11 Leases The Company made cash payments related to its recognized operating leases of $993,000 and $488,000 during the three October 1, 2023 October 2, 2022, six October 1, 2023 October 2, 2022, three October 1, 2023 October 2, 2022, six October 1, 2023 October 2, 2022, October 1, 2023 April 2, 2023, During the three six October 1, 2023 October 2, 2022, Three-Month Periods Ended Six-Month Periods Ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Cost of products sold $ 940 $ 401 $ 1,880 $ 802 Marketing and administrative expenses 97 41 194 82 Total operating lease costs $ 1,037 $ 442 $ 2,074 $ 884 The maturities of the Company’s operating lease liabilities as of October 1, 2023 Fiscal Year 2024 $ 1,980 2025 4,027 2026 4,108 2027 4,086 2028 3,952 2029 663 Total undiscounted operating lease payments 18,816 Less imputed interest 2,414 Operating lease liabilities - net $ 16,402

Note 12 - Stock-based Compensat

Note 12 - Stock-based Compensation	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	Note 12 Stock-based Compensation The Company has three 2006 “2006 2014 “2014 2021 “2021 may no 2006 2014 October 1, 2023, 2021 may three October 1, 2023 October 2, 2022, six October 1, 2023 October 2, 2022, No October 1, 2023. Stock Options: six October 1, 2023 October 2, 2022: Six-Month Periods Ended October 1, 2023 October 2, 2022 Weighted- Weighted- Average Number of Average Number of Exercise Options Exercise Options Price Outstanding Price Outstanding Outstanding at Beginning of Period $ 7.32 735,500 $ 7.39 635,500 Granted 5.26 120,000 6.54 120,000 Exercised - - 4.92 (20,000 ) Expired 6.14 (10,000 ) - - Outstanding at End of Period 7.04 845,500 7.32 735,500 Exercisable at End of Period 7.41 665,500 7.42 499,000 As of October 1, 2023, no six October 1, 2023. three six October 2, 2022 not three six October 2, 2022. may three six October 2, 2022, Stock-based compensation is calculated according to FASB ASC Topic 718, Compensation Stock Compensation, six October 1, 2023 October 2, 2022, two Six-Month Periods Ended October 1, 2023 October 2, 2022 Number of options issued 120,000 120,000 Grant date June 21, 2023 June 7, 2022 Dividend yield 6.08 % 4.89 % Expected volatility 25.00 % 30.00 % Risk free interest rate 4.29 % 2.95 % Contractual term (years) 10.00 10.00 Expected term (years) 3.00 4.00 Forfeiture rate 5.00 % 5.00 % Exercise price (grant-date closing price) per option $ 5.26 $ 6.54 Fair value per option $ 0.46 $ 0.90 During the three October 1, 2023 October 2, 2022, Three-Month Period Ended October 1, 2023 Three-Month Period Ended October 2, 2022 Cost of Marketing & Cost of Marketing & Products Administrative Total Products Administrative Total Options Granted in Fiscal Year Sold Expenses Expense Sold Expenses Expense 2021 $ - $ - $ - $ - $ 15 $ 15 2022 - - - 10 16 26 2023 5 8 13 4 8 12 2024 3 3 6 - - - Total stock option compensation $ 8 $ 11 $ 19 $ 14 $ 39 $ 53 During the six October 1, 2023 October 2, 2022, Six-Month Period Ended October 1, 2023 Six-Month Period Ended October 2, 2022 Cost of Marketing & Cost of Marketing & Products Administrative Total Products Administrative Total Options Granted in Fiscal Year Sold Expenses Expense Sold Expenses Expense 2021 $ - $ - $ - $ 3 $ 26 $ 29 2022 10 21 31 22 46 68 2023 12 17 29 6 10 16 2024 3 4 7 - - - Total stock option compensation $ 25 $ 42 $ 67 $ 31 $ 82 $ 113 As of October 1, 2023, Non-vested Stock Granted to Directors: Number of Shares Fair Value per Share Grant Date Vesting Period (Years) 60,412 $4.85 August 15, 2023 One 46,896 6.65 August 16, 2022 One 40,165 7.47 August 11, 2021 One 41,452 5.79 August 12, 2020 Two The fair value of the non-vested stock granted to the Company’s directors was based on the closing price of the Company’s common stock on the date of each grant. The non-vested stock granted on August 11, 2021 May 1, 2022, The non-vested stock granted on August 16, 2022 2001. February 21, 2023, In August 2023 August 2022, Non-vested Stock Granted to Employees: Number of Shares Fair Value per Share Grant Date Vesting Date 26,000 $4.77 August 14, 2023 August 14, 2024 40,000 5.85 March 21, 2023 March 21, 2025 25,000 7.98 June 9, 2021 June 9, 2022 10,000 7.60 February 22, 2021 February 22, 2023 20,000 4.92 June 10, 2020 June 10, 2022 These shares vest on the dates indicated, assuming continued service. In June 2022, Performance Award Shares: March 1, 2022, ten twenty March 1, 2027; ten twenty March 1, 2027. one third one third first one third second third During the three six October 1, 2023 October 2, 2022, Three-Month Periods Ended Six-Month Periods Ended Stock Granted in Fiscal Year October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 2021 $ - $ - $ - $ 67 2022 55 19 110 359 2023 49 134 137 52 2024 69 52 69 - Total stock grant compensation $ 173 $ 205 $ 316 $ 478 As of October 1, 2023,

Note 13 - Subsequent Events

Note 13 - Subsequent Events	6 Months Ended
	Oct. 01, 2023
Notes to Financial Statements
Subsequent Events [Text Block]	Note 13 Subsequent Events The Company has evaluated all other events which have occurred between October 1, 2023 no

Note 3 - Segment and Related _2

Note 3 - Segment and Related Information (Tables)	6 Months Ended
	Oct. 01, 2023
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three-Month Periods Ended Six-Month Periods Ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Bedding, blankets and accessories $ 9,776 $ 9,503 $ 15,349 $ 17,001 Bibs, toys and disposable products 14,353 9,223 25,903 17,435 Total net sales $ 24,129 $ 18,726 $ 41,252 $ 34,436

Note 7 - Acquisition (Tables)

Note 7 - Acquisition (Tables)	6 Months Ended
	Oct. 01, 2023
Notes Tables
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Tangible assets: Cash and cash equivalents $ 1,270 Accounts receivable 3,112 Inventories 12,578 Prepaid expenses 350 Other assets 91 Operating lease right of use assets 1,009 Property, plant and equipment 194 Total tangible assets 18,604 Amortizable intangible assets: Tradename 300 Licensing relationships 200 Customer relationships 800 Total amortizable intangible assets 1,300 Goodwill 750 Total acquired assets 20,654 Liabilities assumed: Accounts payable 2,048 Accrued wages and benefits 370 Operating lease liabilities, current 226 Other accrued liabilities 308 Operating lease liabilities, noncurrent 783 Total liabilities assumed 3,735 Net acquisition cost $ 16,919
Business Combination, Segment Allocation [Table Text Block]	Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost $ 787,000 Adjustments made during the six-month period ended October 1, 2023: Settlement of the Aggregate Adjustment (488,000 ) Revaluation of inventory as of the Closing Date 387,000 Resolution of pre-acquisition accounts payable 64,000 Net adjustments made during the six-month period ended October 1, 2023 (37,000 ) Amount of goodwill recognized as of October 1, 2023 $ 750,000

Note 10 - Other Intangible As_2

Note 10 - Other Intangible Assets (Tables)	6 Months Ended
	Oct. 01, 2023
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Amortization Expense Gross Amount Accumulated Amortization Three-Month Periods Ended Six-Month Periods Ended October 1, April 2, October 1, April 2, October 1, October 2, October 1, October 2, 2023 2023 2023 2023 2023 2022 2023 2022 Tradename and trademarks $ 2,867 $ 2,867 $ 2,103 $ 2,025 $ 43 $ 35 $ 78 $ 70 Non-compete covenants 98 98 98 98 - - - - Patents 1,601 1,601 1,081 1,055 13 13 26 26 Customer relationships 8,174 8,174 6,474 6,289 92 73 185 145 Licensing relationships 200 200 10 - 5 - 10 - Total other intangible assets $ 12,940 $ 12,940 $ 9,766 $ 9,467 $ 153 $ 121 $ 299 $ 241

Note 11 - Leases (Tables)

Note 11 - Leases (Tables)	6 Months Ended
	Oct. 01, 2023
Notes Tables
Lease, Cost [Table Text Block]	Three-Month Periods Ended Six-Month Periods Ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Cost of products sold $ 940 $ 401 $ 1,880 $ 802 Marketing and administrative expenses 97 41 194 82 Total operating lease costs $ 1,037 $ 442 $ 2,074 $ 884
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	Fiscal Year 2024 $ 1,980 2025 4,027 2026 4,108 2027 4,086 2028 3,952 2029 663 Total undiscounted operating lease payments 18,816 Less imputed interest 2,414 Operating lease liabilities - net $ 16,402

Note 12 - Stock-based Compens_2

Note 12 - Stock-based Compensation (Tables)	6 Months Ended
	Oct. 01, 2023
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Six-Month Periods Ended October 1, 2023 October 2, 2022 Weighted- Weighted- Average Number of Average Number of Exercise Options Exercise Options Price Outstanding Price Outstanding Outstanding at Beginning of Period $ 7.32 735,500 $ 7.39 635,500 Granted 5.26 120,000 6.54 120,000 Exercised - - 4.92 (20,000 ) Expired 6.14 (10,000 ) - - Outstanding at End of Period 7.04 845,500 7.32 735,500 Exercisable at End of Period 7.41 665,500 7.42 499,000
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Six-Month Periods Ended October 1, 2023 October 2, 2022 Number of options issued 120,000 120,000 Grant date June 21, 2023 June 7, 2022 Dividend yield 6.08 % 4.89 % Expected volatility 25.00 % 30.00 % Risk free interest rate 4.29 % 2.95 % Contractual term (years) 10.00 10.00 Expected term (years) 3.00 4.00 Forfeiture rate 5.00 % 5.00 % Exercise price (grant-date closing price) per option $ 5.26 $ 6.54 Fair value per option $ 0.46 $ 0.90
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three-Month Period Ended October 1, 2023 Three-Month Period Ended October 2, 2022 Cost of Marketing & Cost of Marketing & Products Administrative Total Products Administrative Total Options Granted in Fiscal Year Sold Expenses Expense Sold Expenses Expense 2021 $ - $ - $ - $ - $ 15 $ 15 2022 - - - 10 16 26 2023 5 8 13 4 8 12 2024 3 3 6 - - - Total stock option compensation $ 8 $ 11 $ 19 $ 14 $ 39 $ 53 Six-Month Period Ended October 1, 2023 Six-Month Period Ended October 2, 2022 Cost of Marketing & Cost of Marketing & Products Administrative Total Products Administrative Total Options Granted in Fiscal Year Sold Expenses Expense Sold Expenses Expense 2021 $ - $ - $ - $ 3 $ 26 $ 29 2022 10 21 31 22 46 68 2023 12 17 29 6 10 16 2024 3 4 7 - - - Total stock option compensation $ 25 $ 42 $ 67 $ 31 $ 82 $ 113 Three-Month Periods Ended Six-Month Periods Ended Stock Granted in Fiscal Year October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 2021 $ - $ - $ - $ 67 2022 55 19 110 359 2023 49 134 137 52 2024 69 52 69 - Total stock grant compensation $ 173 $ 205 $ 316 $ 478
Schedule of Nonvested Share Activity [Table Text Block]	Number of Shares Fair Value per Share Grant Date Vesting Period (Years) 60,412 $4.85 August 15, 2023 One 46,896 6.65 August 16, 2022 One 40,165 7.47 August 11, 2021 One 41,452 5.79 August 12, 2020 Two Number of Shares Fair Value per Share Grant Date Vesting Date 26,000 $4.77 August 14, 2023 August 14, 2024 40,000 5.85 March 21, 2023 March 21, 2025 25,000 7.98 June 9, 2021 June 9, 2022 10,000 7.60 February 22, 2021 February 22, 2023 20,000 4.92 June 10, 2020 June 10, 2022

Note 2 - Advertising Costs (Det

Note 2 - Advertising Costs (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Advertising Expense	$ 172,000	$ 123,000	$ 364,000	$ 247,000

Note 3 - Segment and Related _3

Note 3 - Segment and Related Information (Details Textual)	3 Months Ended
	Oct. 01, 2023
Number of Operating Segments	1

Note 3 - Segment and Related _4

Note 3 - Segment and Related Information - Segment and Related Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Net sales	$ 24,129	$ 18,726	$ 41,252	$ 34,436
Bedding, Blankets, And Accessories [Member]
Net sales	9,776	9,503	15,349	17,001
Bibs, Bath, Developmental Toy, Feeding, Baby Care and Disposable Products [Member]
Net sales	$ 14,353	$ 9,223	$ 25,903	$ 17,435

Note 4 - Licensing Agreements (

Note 4 - Licensing Agreements (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Cost of Goods and Services Sold	$ 17,533	$ 13,280	$ 29,914	$ 23,837
Royalty [Member]
Cost of Goods and Services Sold	$ 1,500	$ 1,200	$ 2,500	$ 2,300

Note 5 - Income Taxes (Details

Note 5 - Income Taxes (Details Textual)	May 30, 2023 USD ($)
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority	$ (442,000)
Income Tax Examination, Increase (Decrease) in Interest Expense	$ (86,000)

Note 6 - Inventories (Details T

Note 6 - Inventories (Details Textual) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Inventory, Net	$ 35,257	$ 34,211

Note 7 - Acquisition (Details T

Note 7 - Acquisition (Details Textual) - USD ($)		3 Months Ended		6 Months Ended
	Mar. 17, 2023	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022	Sep. 29, 2023	Apr. 02, 2023	Apr. 01, 2023
Goodwill		$ 7,875,000		$ 7,875,000			$ 7,912,000
Amortization of Intangible Assets		153,000	$ 121,000	299,000	$ 241,000
Manhattan Acquisition [Member]
Business Combination, Consideration Transferred	$ 17,000,000
Business Combination, Net Working Capital Adjustments	13,750,000
Business Combination, Aggregate Adjustment of Purchase Price, Amount Received						$ 509,000
Business Combination, Aggregate Adjustment of Purchase Price, Amount Received, Interest Income						21,000
Business Combination, Consideration Transferred, Including Net Working Capital Adjustment	17,400,000
Business Combination, Aggregate Adjustment of Purchase Price, Acquisition Cost						$ 16,900,000
Goodwill	$ 750,000	750,000		750,000			$ 787,000	$ 787,000
Amortization of Intangible Assets		33,000		58,000
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)	11 years
Business Acquisition, Pro Forma Revenue			25,800,000		48,500,000
Business Acquisition, Pro Forma Net Income (Loss)			$ 1,300,000		$ 2,100,000
Manhattan Acquisition [Member] | Trade Names [Member]
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)	15 years
Manhattan Acquisition [Member] | Customer and Licensing Relationships [Member]
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)	10 years
Manhattan Acquisition [Member] | Developmental Toy, Feeding and Baby Care Products [Member]
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual		$ 4,800,000		$ 8,500,000

Note 7 - Acquisition - Estimate

Note 7 - Acquisition - Estimated Fair Value of Identifiable Net Assets (Details) - USD ($)	Oct. 01, 2023	Apr. 02, 2023	Apr. 01, 2023	Mar. 17, 2023
Goodwill	$ 7,875,000	$ 7,912,000
Manhattan Acquisition [Member]
Cash and cash equivalents				$ 1,270,000
Accounts receivable				3,112,000
Inventories				12,578,000
Prepaid expenses				350,000
Other assets				91,000
Operating lease right of use assets				1,009,000
Property, plant and equipment				194,000
Total tangible assets				18,604,000
Amortizable intangible assets:				1,300,000
Goodwill	$ 750,000	$ 787,000	$ 787,000	750,000
Total acquired assets				20,654,000
Accounts payable				2,048,000
Accrued wages and benefits				370,000
Operating lease liabilities, current				226,000
Other accrued liabilities				308,000
Operating lease liabilities, noncurrent				783,000
Total liabilities assumed				3,735,000
Net acquisition cost				16,919,000
Manhattan Acquisition [Member] | Trade Names [Member]
Amortizable intangible assets:				300,000
Manhattan Acquisition [Member] | Licensing Agreements [Member]
Amortizable intangible assets:				200,000
Manhattan Acquisition [Member] | Customer Relationships [Member]
Amortizable intangible assets:				$ 800,000

Note 7 - Acquisition - Goodwill

Note 7 - Acquisition - Goodwill Adjustments (Details)	6 Months Ended
	Oct. 01, 2023 USD ($)
Amount of goodwill recognized as of October 1, 2023	$ 7,875,000
Manhattan Acquisition [Member]
Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost	787,000
Settlement of the Aggregate Adjustment	(488,000)
Revaluation of inventory as of the Closing Date	387,000
Resolution of pre-acquisition accounts payable	64,000
Net adjustments made during the six-month period ended October 1, 2023	(37,000)
Amount of goodwill recognized as of October 1, 2023	$ 750,000

Note 8 - Financing Arrangemen_2

Note 8 - Financing Arrangements (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022	Jul. 02, 2023	Apr. 02, 2023
Selling, General and Administrative Expense	$ 4,036,000	$ 2,736,000	$ 8,082,000	$ 6,149,000
Long-Term Line of Credit	9,800,000		9,800,000			$ 12,700,000
Letters of Credit Outstanding, Amount	0		0			0
Line of Credit Facility, Remaining Borrowing Capacity	20,200,000		20,200,000			20,000,000
Accounts Receivable, after Allowance for Credit Loss, Current	20,300,000		20,300,000			22,800,000
Accounts Receivable, Allowance for Credit Loss, Current	2,400,000		2,400,000			1,500,000
Receivable Due from Factor [Member]
Accounts Receivable, Allowance for Credit Loss, Current	17,100,000		17,100,000			$ 20,700,000
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 35,000,000		$ 35,000,000
Revolving Credit Facility [Member] | Prime Rate [Member]
Debt Instrument Basis Spread Below Variable Rate			0.50%
Debt Instrument, Interest Received on Daily Negative Balances, Basis Spread Below Variable Rate			2%
Revolving Credit Facility [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			1.60%
Debt Instrument, Interest Rate, Effective Percentage	6.90%		6.90%
Letter of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,500,000		$ 1,500,000
Factoring Agreements [Member]
Long-Term Debt					$ 0
Factoring Fees [Member]
Selling, General and Administrative Expense	$ 92,000	$ 79,000	$ 159,000	$ 147,000

Note 9 - Goodwill (Details Text

Note 9 - Goodwill (Details Textual) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Goodwill, Gross	$ 30,800	$ 30,800
Goodwill, Impaired, Accumulated Impairment Loss	22,900	22,900
Goodwill	$ 7,875	$ 7,912

Note 10 - Other Intangible As_3

Note 10 - Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022	Apr. 02, 2023
Finite-lived intangible assets, gross amount	$ 12,940		$ 12,940		$ 12,940
Finite-lived intangible assets, accumulated amortization	9,766		9,766		9,467
Amortization expense	153	$ 121	299	$ 241
Trademarks and Trade Names [Member]
Finite-lived intangible assets, gross amount	2,867		2,867		2,867
Finite-lived intangible assets, accumulated amortization	2,103		2,103		2,025
Amortization expense	43	35	78	70
Noncompete Agreements [Member]
Finite-lived intangible assets, gross amount	98		98		98
Finite-lived intangible assets, accumulated amortization	98		98		98
Amortization expense	0	0	0	0
Patents [Member]
Finite-lived intangible assets, gross amount	1,601		1,601		1,601
Finite-lived intangible assets, accumulated amortization	1,081		1,081		1,055
Amortization expense	13	13	26	26
Customer Relationships [Member]
Finite-lived intangible assets, gross amount	8,174		8,174		8,174
Finite-lived intangible assets, accumulated amortization	6,474		6,474		6,289
Amortization expense	92	73	185	145
Licensing Agreements [Member]
Finite-lived intangible assets, gross amount	200		200		200
Finite-lived intangible assets, accumulated amortization	10		10		$ 0
Amortization expense	$ 5	$ 0	$ 10	$ 0

Note 11 - Leases (Details Textu

Note 11 - Leases (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022	Apr. 02, 2023
Operating Lease, Payments	$ 993,000	$ 488,000	$ 1,400,000	$ 969,000
Operating Lease, Right-of-Use Asset, Periodic Reduction	$ 249,000	$ 20,000	$ 503,000	$ 43,000
Operating Lease, Weighted Average Remaining Lease Term (Year)	4 years 6 months		4 years 6 months		5 years
Operating Lease, Weighted Average Discount Rate, Percent	5.90%		5.90%		5.90%

Note 11 - Leases - Classificati

Note 11 - Leases - Classification of Operating Lease Costs in Consolidated Statements of Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Operating Lease Costs	$ 1,037	$ 442	$ 2,074	$ 884
Cost of Sales [Member]
Operating Lease Costs	940	401	1,880	802
Selling, General and Administrative Expenses [Member]
Operating Lease Costs	$ 97	$ 41	$ 194	$ 82

Note 11 - Leases - Maturities o

Note 11 - Leases - Maturities of Operating Lease Liabilities (Details) $ in Thousands	Oct. 01, 2023 USD ($)
2024	$ 1,980
2025	4,027
2026	4,108
2027	4,086
2028	3,952
2029	663
Total undiscounted operating lease payments	18,816
Less imputed interest	2,414
Operating lease liabilities - net	$ 16,402

Note 12 - Stock-based Compens_3

Note 12 - Stock-based Compensation (Details Textual) - USD ($)						1 Months Ended			3 Months Ended		6 Months Ended
	Feb. 21, 2023	Aug. 16, 2022	May 01, 2022	Mar. 01, 2022	Aug. 11, 2021	Aug. 31, 2023	Aug. 31, 2022	Jun. 30, 2022	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Common Stock, Capital Shares Reserved for Future Issuance (in shares)									559,000		559,000
Share-Based Payment Arrangement, Expense									$ 192,000	$ 258,000	$ 383,000	$ 591,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value										8,000	0	28,000
Proceeds from Stock Options Exercised											$ 0
Payment, Tax Withholding, Share-Based Payment Arrangement										2,000		10,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Month)											9 months
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount									662,000		$ 662,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value									0		0
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense									19,000	$ 53,000	$ 67,000	$ 113,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)											2 years	2 years
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount									$ 86,000		$ 86,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Month)											12 months 15 days
Non-vested Stock Grants [Member] | Former Chairman, President and Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)					8,033
Non-vested Stock Grants [Member] | Non Employee Directors [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number (in shares)			8,033
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested			$ 50,000			$ 168,000	$ 331,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)						35,172	52,856
Non-vested Stock Grants [Member] | Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		11,724
Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number (in shares)	11,724
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested	$ 67,000
Non-vested Stock Grants [Member] | Employee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested								$ 293,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)								45,000
Performance Shares [Member]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instrument Other Than Options Grants In Period Total Grant Date Fair Value				$ 732,000
Performance Shares [Member] | Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)				187,500
Performance Shares [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)				75,000
Share Based Compensation, Grant Conditions, Minimum Per-Share Price (in dollars per share)				$ 8
Share Based Compensation, Grant Conditions, Trading Period (Day)				10 days
Performance Shares [Member] | Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)				112,500
Share Based Compensation, Grant Conditions, Minimum Per-Share Price (in dollars per share)				$ 9
Share Based Compensation, Grant Conditions, Trading Period (Day)				10 days

Note 12 - Stock-based Compens_4

Note 12 - Stock-based Compensation - Stock Option Activity (Details) - $ / shares	6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022
Outstanding, Weighted-average exercise price, beginning balance (in dollars per share)	$ 7.32	$ 7.39
Outstanding, Shares, beginning balance (in shares)	735,500	635,500
Granted, Weighted-average exercise price (in dollars per share)	$ 5.26	$ 6.54
Number of options issued (in shares)	120,000	120,000
Exercised, Weighted-average exercise price (in dollars per share)	$ 0	$ 4.92
Exercised, Shares (in shares)	0	(20,000)
Expired, Weighted-average exercise price (in dollars per share)	$ 6.14	$ 0
Expired, Shares (in shares)	(10,000)	0
Outstanding, Weighted-average exercise price, ending balance (in dollars per share)	$ 7.04	$ 7.32
Outstanding, Shares, ending balance (in shares)	845,500	735,500
Exercisable, Weighted-average exercise price (in dollars per share)	$ 7.41	$ 7.42
Exercisable, Shares (in shares)	665,500	499,000

Note 12 - Stock-based Compens_5

Note 12 - Stock-based Compensation - Estimated Fair Value of Stock Options Assumptions (Details) - $ / shares	6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022
Number of options issued (in shares)	120,000	120,000
June 7, 2022 [Member]
Number of options issued (in shares)	120,000
Grant date	Jun. 21, 2023
Dividend yield	6.08%
Expected volatility	25%
Risk free interest rate	4.29%
Contractual term (years) (Year)	10 years
Expected term (years) (Year)	3 years
Forfeiture rate	5%
Exercise price (grant-date closing price) per option (in dollars per share)	$ 5.26
Fair value per option (in dollars per share)	$ 0.46
June 9, 2021 [Member]
Number of options issued (in shares)		120,000
Grant date		Jun. 07, 2022
Dividend yield		4.89%
Expected volatility		30%
Risk free interest rate		2.95%
Contractual term (years) (Year)		10 years
Expected term (years) (Year)		4 years
Forfeiture rate		5%
Exercise price (grant-date closing price) per option (in dollars per share)		$ 6.54
Fair value per option (in dollars per share)		$ 0.9

Note 12 - Stock-based Compens_6

Note 12 - Stock-based Compensation - Stock Option Compensation (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Allocated Share Based Compensation Expense	$ 192,000	$ 258,000	$ 383,000	$ 591,000
Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	19,000	53,000	67,000	113,000
Fiscal Year 2021 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	15,000	0	29,000
Fiscal Year 2022 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	26,000	31,000	68,000
Fiscal Year 2023 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	13,000	12,000	29,000	16,000
Fiscal Year 2024 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	6,000	0	7,000	0
Cost of Sales [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	8,000	14,000	25,000	31,000
Cost of Sales [Member] | Fiscal Year 2021 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	0	0	3,000
Cost of Sales [Member] | Fiscal Year 2022 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	10,000	10,000	22,000
Cost of Sales [Member] | Fiscal Year 2023 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	5,000	4,000	12,000	6,000
Cost of Sales [Member] | Fiscal Year 2024 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	3,000	0	3,000	0
Marketing and Administrative Expenses [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	11,000	39,000	42,000	82,000
Marketing and Administrative Expenses [Member] | Fiscal Year 2021 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	15,000	0	26,000
Marketing and Administrative Expenses [Member] | Fiscal Year 2022 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	16,000	21,000	46,000
Marketing and Administrative Expenses [Member] | Fiscal Year 2023 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	8,000	8,000	17,000	10,000
Marketing and Administrative Expenses [Member] | Fiscal Year 2024 [Member] | Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	3,000	0	4,000	0
Selling, General and Administrative Expenses [Member] | Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	173,000	205,000	316,000	478,000
Selling, General and Administrative Expenses [Member] | Fiscal Year 2021 [Member] | Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	0	0	0	67,000
Selling, General and Administrative Expenses [Member] | Fiscal Year 2022 [Member] | Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	55,000	19,000	110,000	359,000
Selling, General and Administrative Expenses [Member] | Fiscal Year 2023 [Member] | Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	49,000	134,000	137,000	52,000
Selling, General and Administrative Expenses [Member] | Fiscal Year 2024 [Member] | Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	$ 69,000	$ 52,000	$ 69,000	$ 0

Note 12 - Stock-based Compens_7

Note 12 - Stock-based Compensation - Non-vested Stock to Directors and Employees (Details) - Non-vested Stock Grants [Member]	6 Months Ended
	Oct. 01, 2023 $ / shares shares
August 14, 2023 [Member] | Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 4.77
Number of Shares (in shares) | shares	26,000
March 21, 2023 [Member] | Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 5.85
Number of Shares (in shares) | shares	40,000
June 9, 2021 [Member] | Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 7.98
Number of Shares (in shares) | shares	25,000
February 22, 2021 [Member] | Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 7.6
Number of Shares (in shares) | shares	10,000
June 10, 2020 [Member] | Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 4.92
Number of Shares (in shares) | shares	20,000
Non Employee Directors [Member] | August 15, 2023 [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 4.85
Number of Shares (in shares) | shares	60,412
Vesting Period (Year)	1 year
Non Employee Directors [Member] | August 16, 2022 [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 6.65
Number of Shares (in shares) | shares	46,896
Vesting Period (Year)	1 year
Non Employee Directors [Member] | August 11, 2021 [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 7.47
Number of Shares (in shares) | shares	40,165
Vesting Period (Year)	1 year
Non Employee Directors [Member] | August 12, 2020 [Member]
Fair Value Per Share (in dollars per share) | $ / shares	$ 5.79
Number of Shares (in shares) | shares	41,452
Vesting Period (Year)	2 years